Literature DB >> 39449

Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium.

J D Buck, G J Gross, D C Warltier, S R Jolly, H F Hardman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39449     DOI: 10.1016/0002-9149(79)90284-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Intrinsic sympathomimetic activity and coronary blood flow.

Authors:  A Berdeaux; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  Myocardial functional preservation during ischemia: influence of beta blocking agents.

Authors:  P M Toleikis; C W Tomlinson
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

3.  Role of propranolol in improvement of the relationship between O2 supply and consumption in an ischemic region of the dog heart.

Authors:  R S Conway; H R Weiss
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

4.  Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.

Authors:  K Noguchi; M Sakanashi
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

Review 5.  Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.

Authors:  W H Frishman; R J Goldberg; P Benfield
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

Review 6.  Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.

Authors:  U Elkayam; W S Aronow
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

7.  Bisoprolol improves perfusion of ischaemic myocardium in anaesthetized pigs.

Authors:  L M Sassen; M O den Boer; R J Rensen; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.